Find information on Ependymoma diagnosis, including Spinal Ependymoma, Intraventricular Ependymoma, and Myxopapillary Ependymoma. Learn about clinical documentation requirements, medical coding guidelines, and healthcare best practices for Ependymoma. This resource provides details relevant to medical professionals involved in diagnosing and managing Ependymoma.
Also known as
Ependymoma of spinal cord
Malignant tumor of the ependymal cells lining the spinal cord.
Ependymoma of brain
Malignant tumor arising from ependymal cells within the brain.
Ependymoma, NOS
Malignant ependymoma not otherwise specified.
Benign neoplasm of spinal cord
Benign tumor of the spinal cord, including some ependymomas.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the ependymoma malignant?
When to use each related code
| Description |
|---|
| Tumor arising from ependymal cells lining ventricles, spinal cord |
| Astrocytoma: tumor arising from star-shaped brain cells (astrocytes) |
| Oligodendroglioma: slow-growing tumor from oligodendrocytes |
Anaplastic ependymoma (grade 3) may be miscoded as a lower grade (grade 2 or 1), impacting reimbursement and treatment.
Failing to code the specific location (spinal, intraventricular, myxopapillary) leads to inaccurate data and potential claims issues.
Missing laterality (right, left, bilateral) for spinal ependymomas can affect coding accuracy and statistical reporting.
Q: What are the key radiological features that distinguish ependymoma subtypes like spinal, intraventricular, and myxopapillary ependymoma on MRI?
A: Distinguishing ependymoma subtypes radiologically requires careful evaluation of location, signal characteristics, and enhancement patterns on MRI. Spinal ependymomas often appear as centrally located, well-circumscribed masses within the spinal canal, sometimes showing a "cap sign" of hemosiderin staining. Intraventricular ependymomas typically arise from the walls of the ventricles, frequently obstructing cerebrospinal fluid flow, and may demonstrate heterogeneous enhancement. Myxopapillary ependymomas are almost exclusively found in the filum terminale or conus medullaris region of the spine, often exhibiting a lobulated or "mulberry" appearance with prominent mucinous components. While these features can be suggestive, histopathological analysis remains the gold standard for definitive diagnosis. Explore how advanced MRI techniques, such as diffusion-weighted imaging and perfusion imaging, can further aid in characterizing these subtypes.
Q: How do current treatment guidelines for ependymoma differ for adult patients compared to pediatric patients, considering tumor location and histology?
A: Treatment guidelines for ependymoma take into account both patient age and tumor characteristics. In both adult and pediatric populations, maximal safe surgical resection remains the cornerstone of therapy. Adjuvant radiotherapy is often recommended, especially for incompletely resected tumors, higher-grade lesions, or those located in challenging anatomical locations. However, the specific radiotherapy approach may differ. For pediatric cases, especially those involving the posterior fossa, proton therapy may be considered to minimize long-term radiation-related complications. In adults, conventional radiotherapy techniques may be employed. The role of chemotherapy is less defined, primarily reserved for recurrent or refractory cases. Consider implementing molecular profiling for personalized treatment strategies, particularly in the context of clinical trials investigating novel targeted therapies for ependymoma. Learn more about current clinical trial opportunities for ependymoma patients.
Patient presents with symptoms suggestive of ependymoma, a neuroepithelial tumor arising from ependymal cells lining the ventricles and central canal of the spinal cord. Clinical presentation varies depending on tumor location. Intracranial ependymomas, including intraventricular ependymomas, may manifest with signs of increased intracranial pressure such as headaches, nausea, vomiting, and papilledema. Spinal ependymomas often present with back pain, weakness, sensory changes, and gait disturbances. Myxopapillary ependymoma, a distinct subtype typically located in the filum terminale or conus medullaris region of the spine, may present with similar symptoms. Diagnostic workup includes magnetic resonance imaging (MRI) of the brain andor spine with and without contrast, which is crucial for visualizing the tumor and assessing its extent. Histopathological analysis of a tissue biopsy obtained through surgical resection is essential for definitive diagnosis and grading of the ependymoma. Differential diagnosis includes other central nervous system tumors such as astrocytoma, oligodendroglioma, and choroid plexus papilloma. Treatment planning for ependymoma depends on factors such as tumor location, size, grade, and patient age and overall health. Surgical resection is the primary treatment modality, aiming for maximal safe resection. Adjuvant radiotherapy, particularly for higher-grade tumors or incompletely resected tumors, may be considered. Chemotherapy is less commonly employed, but may be considered in specific cases, particularly for recurrent or progressive disease. Follow-up care includes regular neurological examinations and imaging surveillance to monitor for recurrence or progression.